| Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
|---|
| 07/09/2009 | CA2710477A1 Tetrasubstituted benzenes |
| 07/08/2009 | EP2076483A2 Methods of making organic compounds by metathesis and hydrocyanation |
| 07/08/2009 | EP2076482A1 Method for the production of alpha-keto acids and esters thereof |
| 07/08/2009 | CN101479230A Biomarkers for diagnosing multiple sclerosis, and methods thereof |
| 07/07/2009 | US7557244 Substituted biphenyl carboxylic acids and derivatives thereof |
| 07/07/2009 | US7557143 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones |
| 07/02/2009 | US20090170908 Spiro compounds and pharmaceutical use thereof |
| 07/01/2009 | EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor |
| 07/01/2009 | CN101468949A Antineoplastic novel compound in immature exocarpof Juglans mandshurica Maxim, method for determining content thereof and use |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/25/2009 | WO2009078965A1 An improved process to prepare treprostinil, the active ingredient in remodulin® |
| 06/25/2009 | WO2009077383A1 Method for preparing optionally substituted p-hydroxymandelic compounds and derivatives thereof |
| 06/25/2009 | US20090163737 Novel process for the preparation of chiral compounds derived from hexanoic acid esters and intermediates used in the synthesis of chiral 2-(bromomethyl)-2-ethylhexanoic acid |
| 06/25/2009 | US20090163653 Perfluorocarboxylic acid salt and process for producing it |
| 06/25/2009 | US20090163576 Compounds for the treatment of metabolic disorders |
| 06/25/2009 | CA2710205A1 An improved process to prepare treprostinil, the active ingredient in remodulin |
| 06/24/2009 | EP2072494A1 Cosmetic and pharmaceutical compositions |
| 06/24/2009 | CN101462947A Preparation of (R) -4-phenyl-2-hydroxybutyrate |
| 06/24/2009 | CN101462946A Method for preparing ethanol acid by catalytic oxidation of biformyl |
| 06/24/2009 | CN100502846C 3,4,5,-substituted benzyl ethylene derivatives and their preparation and use |
| 06/23/2009 | US7550613 alpha-methoxy docosahexanoic acid ethyl ester, alpha-iodo-docosahexanoic acid ethyl ester; antidiabetic for diabetes type 2, cardiovascular disorders, obesity, amyloidosis, prophylaxis; free of 4,7,10,13,16,19-docosahexanoic acid ( DHA), alpha-methyl DHA, alpha-methyl DHA-methyl ester |
| 06/21/2009 | CA2646775A1 Cosmetic and pharmaceutical compositions |
| 06/18/2009 | WO2009073947A1 ORGANIC SALTS OF β-ALANINE |
| 06/18/2009 | WO2009073943A1 Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (hica) |
| 06/18/2009 | US20090156861 Novel carboxylic acid compound, use thereof, and process for producing the same |
| 06/18/2009 | US20090156673 Anti-inflammatory actions of neuroprotectin d1/protectin d1 and it's natural stereoisomers |
| 06/17/2009 | EP2069866A2 Photocurable compositions |
| 06/17/2009 | CN101460444A Novel carboxylic acid compound, use thereof, and process for producing the same |
| 06/17/2009 | CN100500636C Method of extracting amygdalic acid using strong alkali anion exchange resin |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547729 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same |
| 06/16/2009 | CA2414847C Process for the preparation of substituted octanoyl amides |
| 06/11/2009 | US20090149548 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 06/11/2009 | US20090149538 Aspirin-Triggered Lipid Mediators |
| 06/10/2009 | EP2067764A1 Process for the preparation of pure acitretin |
| 06/10/2009 | EP2066615A2 Cyclopentane derivatives as antiglaucoma agents |
| 06/10/2009 | CN101454268A Metal complexes comprising a ligand derived from 2-aryl-2-hydroxyacetic acid and a divalent or trivalent metal cation, and their use |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544821 9,15,16-trihydroxy-10-oxo-12(Z)-octadecenoic acid; plant flower budding promoting agent; excellent stability, needed low concentration |
| 06/09/2009 | US7544800 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 06/04/2009 | WO2009069450A1 Novel bis(formylphenyl) compound and novel polynuclear polyphenol compound derived from the same |
| 06/04/2009 | WO2009030887A3 Bis-aromatic compounds useful in the treatment of inflammation |
| 06/04/2009 | US20090143544 Having an unsaturated fatty acid or fatty ester; metathesis of the feedstock with a lower olefin; the resulting vinyl ester monomer may be epoxidized, hydroformylated or reductively aminated before oligomerization or polymerization to produce omega-epoxy, hydroxy, or amino vinyl esters |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | CN101445451A Method for preparing high-purity salvianic acid A sodium |
| 06/03/2009 | CN101445450A Method of ozone oxidation synthesis glyoxylate monohydrate |
| 06/03/2009 | CN101445449A Production method and device for sodium gluconate energy-saving triple effect concentration and crystallization |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/03/2009 | CN100494157C Eudesmane type sesquiterpenes acid and application thereof |
| 05/28/2009 | US20090137835 Processes for intermediates for macrocyclic compounds |
| 05/28/2009 | US20090137609 Vitamin d-like compound |
| 05/28/2009 | US20090137567 Methods for Treating Blood Disorders |
| 05/28/2009 | US20090137561 Substituted biphenyl GPR40 modulators |
| 05/27/2009 | EP2062874A1 Process and intermediates for the preparation of aliskiren |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | CN101440032A Gemfibrozil polycrystalline type and preparation thereof |
| 05/27/2009 | CN101440031A Method for preparing high-purity calcium lactate from oyster shell |
| 05/27/2009 | CN101440012A Method for purifying alpha-oxo-carboxyl acid |
| 05/27/2009 | CN100491320C Method for producing potassium citrate through continuous condensing crystallizing, and apparatus for realizing the method |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538236 Ozonolysis of vegetable oil (canola) followed by hydrogenation to produce nonanol, hexanol, propanol, and/or 1,3-propanediol; producing a polyol from a renewable feedstock |
| 05/21/2009 | US20090131701 producing conjugated linoleic and linolenic acid triglycerides; mixture of glycerol and fatty acids or fatty acid derivatives is reacted in the presence of an enzymatic catalyst to form triglyceride esters of fatty acids ; reduces production energy usage; industrial production |
| 05/21/2009 | US20090131340 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
| 05/21/2009 | US20090130717 Novel K04-0144 Substance and a Process for Production Thereof |
| 05/20/2009 | CN201241050Y Calcium lactate three-effective reversed flow vaporizing device |
| 05/20/2009 | CN101434970A Double decomposition precipitation transformation production method of potassium citrate |
| 05/20/2009 | CN101434535A Preparation of natural ferulaic acid |
| 05/20/2009 | CN101434534A Preparation of salvianic acid A sodium pure product |
| 05/20/2009 | CN101434533A Novel preparation of sofalcone |
| 05/20/2009 | CN101434532A Method for preparing high-purity calcium gluconate from oyster shell |
| 05/20/2009 | CN101434517A Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/14/2009 | WO2009061999A1 Fluoroolefin monomers and copolymers thereof |
| 05/14/2009 | WO2009060209A1 6,6-fused bicyclic aromatic compounds and their therapeuti use |
| 05/14/2009 | US20090123555 Stimulateable Polymer Particles Exhibiting Reactive Functions, Method for the Production and the Use Thereof |
| 05/13/2009 | EP2058293A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 05/13/2009 | EP2058291A1 Perfluorocarboxylic acid salt and method for producing the same |
| 05/13/2009 | EP1473298B1 Supermolecular carboplatinum derivatives, their preparation and pharmaceutical composition containing them as active ingredient and applications of the compositions |
| 05/13/2009 | EP1259474B1 Calcium dicarboxylate ethers, methods of making same |
| 05/13/2009 | CN101429116A Process for the preparation of pure acitretin |
| 05/12/2009 | CA2306087C Lactic acid processing; methods; arrangements; and, products |
| 05/07/2009 | WO2009055953A1 Flavour-modulating compounds |
| 05/07/2009 | US20090118541 Method for producing glycolic acid |
| 05/07/2009 | US20090118540 Method For Producing Pyruvic Acid |
| 05/07/2009 | US20090118532 Process for the Synthesis of Mandipropamid and Derivatives Thereof |
| 05/07/2009 | US20090118372 Inhibitors Of Biotin Protein Ligase |
| 05/07/2009 | US20090118317 Statin-Carboxyalkylether Combinations |
| 05/07/2009 | US20090118289 (Biphenyl) Carboxylic Acids and Derivatives Thereof |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090117042 Imaging agents and methods of imaging NAALADase or PSMA |
| 05/07/2009 | DE102007052640A1 Verfahren zur Hydroformylierung A process for the hydroformylation |
| 05/06/2009 | EP2054376A1 Process for preparing carboxamides by hydrolysis of carboxylic acid nitriles in the presence of a catalyst comprising manganese dioxide |
| 05/06/2009 | EP2054368A2 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 05/06/2009 | CN101426755A Method for preparing an organic amine-lactic acid complex |
| 05/06/2009 | CN100484400C Diphenylethylene compound |
| 04/30/2009 | WO2009054479A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | WO2007011740A3 A powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis |
| 04/30/2009 | US20090111859 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes |
| 04/30/2009 | CA2704013A1 Spiro-ring compound and use thereof for medical purposes |
| 04/29/2009 | EP2053032A1 Method for producing optically active hydroxycarboxylic acid derivative or salt thereof |
| 04/29/2009 | EP2051959A1 A novel process for preparing 3-amino-5-fluoro-4-dialkoxypentanoic acid ester |